ISSN: 2157-7013
+44 1300 500008
Commentary - (2024)Volume 15, Issue 1
Live cell therapy, also known as cellular therapy or cellular medicine, is a holistic approach that utilizes injections of live animal cells to purportedly rejuvenate and regenerate damaged tissues and organs in the human body. This alternative medical practice traces its roots back to the early 20th century and has gained popularity in recent years as a form of anti-aging treatment and a supposed remedy for various health conditions. Advocates of live cell therapy claim that it can enhance vitality, improve immune function, and even slow down the aging process, but the scientific evidence supporting these assertions remains controversial.
Mechanisms and claims
Proponents of live cell therapy assert that the injection of live animal cells, typically from organs such as the liver, placenta, or embryo, can introduce beneficial factors and stimulate regeneration in the recipient's body.
They argue that these live cells contain growth factors, enzymes, and other bioactive molecules that can promote tissue repair, modulate immune responses, and restore youthful vigour. However, the mechanisms underlying these purported effects are not well-understood, and scientific evidence supporting the efficacy of live cell therapy is limited and largely anecdotal.
Controversy and lack of scientific evidence
Despite its long history and widespread use in some alternative medicine circles, live cell therapy remains a highly controversial practice within the medical community.
Critics argue that the claims made by proponents of live cell therapy are not supported by rigorous scientific evidence and that the risks associated with the procedure may outweigh any potential benefits. Furthermore, the lack of standardized protocols for cell preparation, dosage, and administration makes it difficult to evaluate the safety and efficacy of live cell therapy in a systematic manner.
Regulatory oversight and legal status
The regulatory oversight of live cell therapy varies widely from country to country, with some jurisdictions strictly regulating or outright banning the practice due to concerns about safety and efficacy. In the United States, for example, the Food and Drug Administration (FDA) considers live cell therapy to be a form of biological product and regulates it accordingly.
Potential risks and side effects
Like any medical procedure, live cell therapy carries potential risks and side effects that must be carefully considered by patients and healthcare providers. These risks include infection, allergic reactions, immune rejection, and the transmission of infectious diseases from donor animals to recipients. Additionally, there is a lack of long-term safety data on the use of live cell therapy, raising concerns about its potential for causing adverse effects or long-term complications.
Ethical considerations
Live cell therapy also raises ethical concerns related to the use of animal-derived cells and tissues in medical treatments. Critics argue that the extraction of cells from donor animals, often through invasive procedures or slaughter, raises questions about animal welfare and the ethical treatment of animals.
Citation: Das A (2024) Scrutinizing the Experimental Evidence Supporting Live Cell Therapy Innovations. J Cell Sci Therapy. 15:435.
Received: 02-Jan-2024, Manuscript No. JCEST-24-29677; Editor assigned: 05-Jan-2024, Pre QC No. JCEST-24-29677 (PQ); Reviewed: 19-Jan-2024, QC No. JCEST-24-29677; Revised: 26-Jan-2024, Manuscript No. JCEST-24-29677 (R); Accepted: 02-Feb-2024 , DOI: 10.35248/2157-7013.24.15.435
Copyright: © 2024 Das A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.